Brief: Ipsen Q1 Revenue At EUR 918.8 Mln
16/04/2025 05:59
April 16 (Reuters) - Ipsen SA IPN.PA: Q1 REVENUE EUR 918.8 MILLION CONFIRMS FULL-YEAR 2025 FINANCIAL GUIDANCE EXPECTS FULL-YEAR 2025 SALES GROWTH GREATER THAN 5.0% Source text: ID:nGNE2PtdGJ Further company coverage: IPN.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 587 785 110;))
Recent news on Ipsen SA
See all newsFulcrum falls after discontinuing sickle cell drug program
Fulcrum falls after discontinuing sickle cell drug program
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
Fulcrum Therapeutics falls after scrapping sickle cell drug development
Brief: Ipsen's IQIRVO Shows Meaningful Fatigue Improvements In Moderate-To-Severe PBC Patients